Combined effect of SAR-endolysin LysKpV475 with polymyxin B and Salmonella bacteriophage phSE-5.

IF 2.6 4区 生物学 Q3 MICROBIOLOGY
Marco Gontijo, Mateus Pereira Teles, Hugo Martins Correia, Genesy Pérez Jorge, Isabella Carolina Rodrigues Santos Goes, Anthony Jhoao Fasabi Flores, Márcia Braz, Lucas de Moraes Ceseti, Priscila Zonzini Ramos, Ivan Rosa E Silva, Pedro Marcus Pereira Vidigal, Jörg Kobarg, Rafael Miguez Couñago, Cristina Elisa Alvarez-Martinez, Carla Pereira, Carmen S R Freire, Adelaide Almeida, Marcelo Brocchi
{"title":"Combined effect of SAR-endolysin LysKpV475 with polymyxin B and <i>Salmonella</i> bacteriophage phSE-5.","authors":"Marco Gontijo, Mateus Pereira Teles, Hugo Martins Correia, Genesy Pérez Jorge, Isabella Carolina Rodrigues Santos Goes, Anthony Jhoao Fasabi Flores, Márcia Braz, Lucas de Moraes Ceseti, Priscila Zonzini Ramos, Ivan Rosa E Silva, Pedro Marcus Pereira Vidigal, Jörg Kobarg, Rafael Miguez Couñago, Cristina Elisa Alvarez-Martinez, Carla Pereira, Carmen S R Freire, Adelaide Almeida, Marcelo Brocchi","doi":"10.1099/mic.0.001462","DOIUrl":null,"url":null,"abstract":"<p><p>Endolysins are bacteriophage (or phage)-encoded enzymes that catalyse the peptidoglycan breakdown in the bacterial cell wall. The exogenous action of recombinant phage endolysins against Gram-positive organisms has been extensively studied. However, the outer membrane acts as a physical barrier when considering the use of recombinant endolysins to combat Gram-negative bacteria. This study aimed to evaluate the antimicrobial activity of the SAR-endolysin LysKpV475 against Gram-negative bacteria as single or combined therapies, using an outer membrane permeabilizer (polymyxin B) and a phage, free or immobilized in a pullulan matrix. In the first step, the endolysin LysKpV475 in solution, alone and combined with polymyxin B, was tested <i>in vitro</i> and <i>in vivo</i> against ten Gram-negative bacteria, including highly virulent strains and multidrug-resistant isolates. In the second step, the lyophilized LysKpV475 endolysin was combined with the phage phSE-5 and investigated, free or immobilized in a pullulan matrix, against <i>Salmonella enterica</i> subsp. <i>enterica</i> serovar Typhimurium ATCC 13311. The bacteriostatic action of purified LysKpV475 varied between 8.125 μg ml<sup>-1</sup> against <i>Pseudomonas aeruginosa</i> ATCC 27853, 16.25 μg ml<sup>-1</sup> against <i>S</i>. <i>enterica</i> Typhimurium ATCC 13311, and 32.50 μg ml<sup>-1</sup> against <i>Klebsiella pneumoniae</i> ATCC BAA-2146 and <i>Enterobacter cloacae</i> P2224. LysKpV475 showed bactericidal activity only for <i>P. aeruginosa</i> ATCC 27853 (32.50 μg ml<sup>-1</sup>) and <i>P. aeruginosa</i> P2307 (65.00 μg ml<sup>-1</sup>) at the tested concentrations. The effect of the LysKpV475 combined with polymyxin B increased against <i>K. pneumoniae</i> ATCC BAA-2146 [fractional inhibitory concentration index (FICI) 0.34; a value lower than 1.0 indicates an additive/combined effect] and <i>S</i>. <i>enterica</i> Typhimurium ATCC 13311 (FICI 0.93). A synergistic effect against <i>S</i>. <i>enterica</i> Typhimurium was also observed when the lyophilized LysKpV475 at ⅔ MIC was combined with the phage phSE-5 (m.o.i. of 100). The lyophilized LysKpV475 immobilized in a pullulan matrix maintained a significant S<i>almonella</i> reduction of 2 logs after 6 h of treatment. These results demonstrate the potential of SAR-endolysins, alone or in combination with other treatments, in the free form or immobilized in solid matrices, which paves the way for their application in different areas, such as in biocontrol at the food processing stage, biosanitation of food contact surfaces and biopreservation of processed food in active food packing.</p>","PeriodicalId":49819,"journal":{"name":"Microbiology-Sgm","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170124/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbiology-Sgm","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1099/mic.0.001462","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Endolysins are bacteriophage (or phage)-encoded enzymes that catalyse the peptidoglycan breakdown in the bacterial cell wall. The exogenous action of recombinant phage endolysins against Gram-positive organisms has been extensively studied. However, the outer membrane acts as a physical barrier when considering the use of recombinant endolysins to combat Gram-negative bacteria. This study aimed to evaluate the antimicrobial activity of the SAR-endolysin LysKpV475 against Gram-negative bacteria as single or combined therapies, using an outer membrane permeabilizer (polymyxin B) and a phage, free or immobilized in a pullulan matrix. In the first step, the endolysin LysKpV475 in solution, alone and combined with polymyxin B, was tested in vitro and in vivo against ten Gram-negative bacteria, including highly virulent strains and multidrug-resistant isolates. In the second step, the lyophilized LysKpV475 endolysin was combined with the phage phSE-5 and investigated, free or immobilized in a pullulan matrix, against Salmonella enterica subsp. enterica serovar Typhimurium ATCC 13311. The bacteriostatic action of purified LysKpV475 varied between 8.125 μg ml-1 against Pseudomonas aeruginosa ATCC 27853, 16.25 μg ml-1 against S. enterica Typhimurium ATCC 13311, and 32.50 μg ml-1 against Klebsiella pneumoniae ATCC BAA-2146 and Enterobacter cloacae P2224. LysKpV475 showed bactericidal activity only for P. aeruginosa ATCC 27853 (32.50 μg ml-1) and P. aeruginosa P2307 (65.00 μg ml-1) at the tested concentrations. The effect of the LysKpV475 combined with polymyxin B increased against K. pneumoniae ATCC BAA-2146 [fractional inhibitory concentration index (FICI) 0.34; a value lower than 1.0 indicates an additive/combined effect] and S. enterica Typhimurium ATCC 13311 (FICI 0.93). A synergistic effect against S. enterica Typhimurium was also observed when the lyophilized LysKpV475 at ⅔ MIC was combined with the phage phSE-5 (m.o.i. of 100). The lyophilized LysKpV475 immobilized in a pullulan matrix maintained a significant Salmonella reduction of 2 logs after 6 h of treatment. These results demonstrate the potential of SAR-endolysins, alone or in combination with other treatments, in the free form or immobilized in solid matrices, which paves the way for their application in different areas, such as in biocontrol at the food processing stage, biosanitation of food contact surfaces and biopreservation of processed food in active food packing.

SAR-endolysin LysKpV475 与多粘菌素 B 和沙门氏菌噬菌体 phSE-5 的联合作用。
内溶素是噬菌体(或噬菌体)编码的酶,可催化细菌细胞壁中肽聚糖的分解。重组噬菌体内溶素对革兰氏阳性菌的外源性作用已被广泛研究。然而,当考虑使用重组噬菌体内溶酶体来对付革兰氏阴性细菌时,外膜会起到物理屏障的作用。本研究旨在评估 SAR 内溶素 LysKpV475 作为单一疗法或联合疗法对革兰氏阴性菌的抗菌活性,使用外膜渗透剂(多粘菌素 B)和噬菌体(游离或固定在拉普兰基质中)。第一步,对溶液中的内溶菌素 LysKpV475(单独使用或与多粘菌素 B 结合使用)进行了体外和体内试验,以对抗十种革兰氏阴性细菌,包括高毒性菌株和耐多药分离菌株。第二步,将冻干的 LysKpV475 内溶解素与噬菌体 phSE-5 结合起来,研究其在游离或固定在拉普兰基质中对肠炎沙门氏菌亚种 Typhimurium ATCC 13311 的作用。纯化的 LysKpV475 对铜绿假单胞菌 ATCC 27853 的抑菌作用为 8.125 μg ml-1,对伤寒沙门氏菌 ATCC 13311 的抑菌作用为 16.25 μg ml-1,对肺炎克雷伯菌 ATCC BAA-2146 和肠杆菌 P2224 的抑菌作用为 32.50 μg ml-1。在测试浓度下,LysKpV475 仅对铜绿假单胞菌 ATCC 27853(32.50 μg ml-1)和铜绿假单胞菌 P2307(65.00 μg ml-1)具有杀菌活性。LysKpV475 与多粘菌素 B 联合使用,对肺炎克氏菌 ATCC BAA-2146 [抑制浓度分数指数(FICI)为 0.34;低于 1.0 表示有添加/联合作用] 和伤寒杆菌 ATCC 13311 (FICI 0.93)的作用增强。当 MIC ⅔ 的冻干 LysKpV475 与 phSE-5 噬菌体(m.o.i. 100)结合使用时,也观察到了对伤寒杆菌的协同作用。冻干的 LysKpV475 被固定在拉普兰基质中,经过 6 小时的处理后,沙门氏菌的数量显著减少了 2 个对数值。这些结果表明了 SAR 内溶素的潜力,无论是单独使用还是与其他处理方法结合使用,无论是以游离形式还是固定在固体基质中,这都为它们在不同领域的应用铺平了道路,例如食品加工阶段的生物控制、食品接触表面的生物消毒以及活性食品包装中加工食品的生物保存。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbiology-Sgm
Microbiology-Sgm 生物-微生物学
CiteScore
4.60
自引率
7.10%
发文量
132
审稿时长
3.0 months
期刊介绍: We publish high-quality original research on bacteria, fungi, protists, archaea, algae, parasites and other microscopic life forms. Topics include but are not limited to: Antimicrobials and antimicrobial resistance Bacteriology and parasitology Biochemistry and biophysics Biofilms and biological systems Biotechnology and bioremediation Cell biology and signalling Chemical biology Cross-disciplinary work Ecology and environmental microbiology Food microbiology Genetics Host–microbe interactions Microbial methods and techniques Microscopy and imaging Omics, including genomics, proteomics and metabolomics Physiology and metabolism Systems biology and synthetic biology The microbiome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信